PENNA, SARA
 Distribuzione geografica
Continente #
NA - Nord America 608
EU - Europa 306
AS - Asia 137
Totale 1.051
Nazione #
US - Stati Uniti d'America 597
CN - Cina 88
SE - Svezia 64
IT - Italia 57
DE - Germania 46
IE - Irlanda 36
AT - Austria 35
DK - Danimarca 24
HK - Hong Kong 20
GB - Regno Unito 19
VN - Vietnam 13
CA - Canada 9
IN - India 6
RU - Federazione Russa 6
BE - Belgio 5
UA - Ucraina 5
JP - Giappone 4
TR - Turchia 4
FI - Finlandia 3
FR - Francia 2
IR - Iran 2
MX - Messico 2
PL - Polonia 2
CH - Svizzera 1
RO - Romania 1
Totale 1.051
Città #
Ann Arbor 183
Wilmington 72
Chandler 64
Ashburn 47
Fairfield 47
Frankfurt am Main 42
Dublin 36
Vienna 34
Beijing 27
Woodbridge 23
Milan 21
Hong Kong 20
Seattle 19
Hangzhou 18
Houston 16
Cambridge 15
Princeton 14
Dong Ket 13
Dearborn 9
Jacksonville 8
Nanjing 8
Shanghai 7
Xian 7
New York 6
Brussels 5
Cagliari 5
Toronto 5
Edmonton 4
Lawrence 4
Tokyo 4
Boardman 3
Cusano Milanino 3
Tianjin 3
Washington 3
Zhengzhou 3
Altamura 2
Andover 2
Ardabil 2
Campeche 2
Chongqing 2
Guangzhou 2
Hebei 2
Jiaxing 2
Kiev 2
Kocaeli 2
Kunming 2
Monmouth Junction 2
Mountain View 2
Rome 2
San Diego 2
Shenyang 2
Warsaw 2
Bologna 1
Empoli 1
Falls Church 1
Fremont 1
Helsinki 1
Irkutsk 1
Kilburn 1
Leawood 1
Leeds 1
Los Altos 1
New Delhi 1
Oxford 1
Paderborn 1
Parma 1
Phoenix 1
Ravenna 1
Serio 1
Triuggio 1
Wuhan 1
Totale 851
Nome #
Two mutations in mitochondrial ATP6 gene of ATP synthase, related to human cancer, affect ROS, calcium homeostasis and mitochondrial permeability transition in yeast 337
Novel roles for ion transporters in cell death pathways in budding yeast 200
One disease, many genes: Implications for the treatment of osteopetroses 159
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis 148
Two cancer cancer-related mutations in ATP synthase mitochondrial ATP6 gene impact the ATP synthase dimers formation during permeability transition 144
Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation 128
Development of novel cell based therapeutic approaches to correct primary and secondary bone defects. 63
Totale 1.179
Categoria #
all - tutte 2.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.743


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 5 5 12
2019/2020312 27 45 10 13 18 30 34 24 46 35 26 4
2020/2021277 10 12 51 48 17 21 16 23 13 29 14 23
2021/2022125 15 19 13 13 3 11 8 7 1 11 6 18
2022/2023197 13 63 27 22 11 32 0 10 13 1 4 1
2023/2024123 5 5 0 15 19 39 22 12 4 2 0 0
Totale 1.179